Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is routinely used for advanced or metastasized neuroendocrine tumours (NET). To prevent nephrotoxicity, positively charged amino acids (AA) are co-infused. The aim of this study was to correlate the risk for therapy-related hyperkalaemia with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lückerath, Katharina, Schirbel, Andreas, Strate, Alexander, Buck, Andreas K, Herrmann, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412194/
https://www.ncbi.nlm.nih.gov/pubmed/25977877
http://dx.doi.org/10.1186/s13550-014-0046-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412194/
https://www.ncbi.nlm.nih.gov/pubmed/25977877
http://dx.doi.org/10.1186/s13550-014-0046-2

Ejemplares similares